Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

被引：0
|
作者：
Wenxing Chen
Yanhong Pan
Siliang Wang
Yuping Liu
Guangying Chen
Liang Zhou
Wenting Ni
Aiyun Wang
Yin Lu
机构：
[1] Nanjing University of Chinese Medicine,School of Pharmacy
[2] Nanjing University of Chinese Medicine,Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica
[3] Hainan Normal University,College of Chemistry and Chemical Engineering
来源：
BMC Cancer | / 17卷
关键词：
Cryptotanshinone; AMPK; TSC2; mTORC1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium
    Y Zhou
    P Rychahou
    Q Wang
    H L Weiss
    B M Evers
    Cell Death & Disease, 2015, 6 : e1631 - e1631
  • [32] TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium
    Zhou, Y.
    Rychahou, P.
    Wang, Q.
    Weiss, H. L.
    Evers, B. M.
    CELL DEATH & DISEASE, 2015, 6 : e1631 - e1631
  • [33] Ablation of TSC2 Enhances Mitochondrial Function Via Activation of mTORC1 in β Cells
    Koyanagi, Maki
    Kido, Yoshiaki
    Asahara, Shun-Ichiro
    Shigeyama, Yutaka
    Matsuda, Tomokazu
    Shibutani, Yuki
    Fuchita, Megumi
    Noda, Tetsuo
    Seino, Susumu
    Kasuga, Masato
    DIABETES, 2010, 59 : A91 - A91
  • [34] Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity (vol 5, e11058, 201226)
    Carroll, Bernadette
    Maetzel, Dorothea
    Maddocks, Oliver D. K.
    Otten, Gisela
    Ratcliff, Matthew
    Smith, Graham R.
    Dunlop, Elaine A.
    Passos, Joao F.
    Davies, Owen Richard
    Jaenisch, Rudolf
    Tee, Andrew R.
    Sarkar, Sovan
    Korolchuk, Viktor I.
    ELIFE, 2020, 9
  • [35] Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1
    Tripathi, Durga N.
    Chowdhury, Rajdeep
    Trudel, Laura J.
    Tee, Andrew R.
    Slack, Rebecca S.
    Walker, Cheryl Lyn
    Wogan, Gerald N.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (32) : E2950 - E2957
  • [36] mTORC1/2 inhibition as a treatment strategy for subtypes of colorectal cancer
    Fricke, Stephanie
    Pasch, Cheri
    Payne, Susan
    Yueh, Alexander
    Foley, Tyler
    Korkos, Demetra
    Van De Hey, Dana
    Clipson, Linda
    Deming, Dustin
    CANCER RESEARCH, 2016, 76
  • [37] mTORC1/2 kinase inhibition in an animal model of endometrial cancer
    Korets, S.
    Badura, M.
    Silvera, D.
    Venuto, T.
    Blank, S.
    Schneider, R.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S133 - S134
  • [38] Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: Dependence on glucose concentration and role of AMPK
    Sinnett-Smith, James
    Kisfalvi, Krisztina
    Kui, Robert
    Rozengurt, Enrique
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 430 (01) : 352 - 357
  • [39] Inhibition of mTORC1 by Astrin and Stress Granules Prevents Apoptosis in Cancer Cells
    Thedieck, Kathrin
    Holzwarth, Birgit
    Prentzell, Mirja Tamara
    Boehlke, Christopher
    Klaesener, Kathrin
    Ruf, Stefanie
    Sonntag, Annika Gwendolin
    Maerz, Lars
    Grellscheid, Sushma-Nagaraja
    Kremmer, Elisabeth
    Nitschke, Roland
    Kuehn, E. Wolfgang
    Jonker, Johan W.
    Groen, Albert K.
    Reth, Michael
    Hall, Michael N.
    Baumeister, Ralf
    CELL, 2013, 154 (04) : 859 - 874
  • [40] Receptor-Recognized α2-Macroglobulin Binds to Cell Surface-Associated GRP78 and Activates mTORC1 and mTORC2 Signaling in Prostate Cancer Cells
    Misra, Uma K.
    Pizzo, Salvatore V.
    PLOS ONE, 2012, 7 (12):
12345